ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRO signaling in cancer-associated fibroblasts

Chen, Weicong; Yang, Xuemei; Sun, Jialing; Chen, Yuyao; Zhao, Wenting; He, Chunyu; An, Haiyan; Pang, Jie; Xu, Wei; Wen, Bin*; Sun, Haitao*; He, Songqi*广州中医药大学; 南方医科大学
Journal of Ethnopharmacology2023-1-30DOI: 10.1016/j.jep.2022.115825
1被引9阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Biejiajian pill (BJJP) is a canonical formula that is clinically used to treat chronic liver disease, especially to decrease the incidence of hepatocellular carcinoma (HCC). However, the mechanisms underlying the prevention of HCC progression by BJJP remain unclear.Aim of the study: This study aimed to determine whether BJJP inhibits HCC progression by downregulating platelet-derived growth factor receptor beta (PDGFRO) signaling in cancer-associated fibroblasts (CAFs) in a mouse model of diethylnitrosamine (DEN)/carbon tetrachloride (CCl4)-induced HCC.Materials and methods: C57BL/6 male mice were intraperitoneally injected with DEN 2 weeks after birth, followed by repeated injections of CCl4 weekly from 6 weeks of age onwards, to recapitulate features of HCC. At week 14, BJJP was orally administered to mice. The effects of BJJP on HCC progression were evaluated using histology, immunohistochemistry, and serum biochemical marker levels. Transcriptome analysis, molecular docking, quantitative real-time PCR, and Western blot were used to study the genes targeted by BJJP and the associated signaling pathway. The effects of BJJP on PDGFRO signaling in CAFs and the underlying mechanism were demonstrated.Results: BJJP treatment significantly suppressed carcinogenesis and cancer progression, and it ameliorated liver inflammation in mice with HCC. A total of 176 genes, including PDGFRO, were significantly downregulated after BJJP treatment and five components of BJJP with high binding affinity to PDGFRO were identified. BJJP inhibited the phosphorylation of phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), and glycogen synthase kinase 3 beta (GSK3O) by suppressing PDGFRO expression in CAFs, and it also downregulated the expression of the downstream proteins hepatocyte growth factor (HGF) and vascular endothelial growth factor A (VEGF-A). Furthermore, BJJP-containing serum consistently reduced PDGFRO, HGF, and VEGF-A expression levels in HSC-derived CAFs in vitro. Importantly, PDGF-BB induced PDGFRO activation in CAFs and both BJJP and sunitinib (a kinase inhibitor) inhibited PDGF-BB/PDGFRO signaling.Conclusion: BJJP inhibits the progression of HCC through suppressing VEGF-A and HGF expression in CAFs by downregulating PDGFRO signaling.

学科与关键词

关键词
Biejiajian pillHepatocellular carcinomaCancer-associated fibroblastsPlatelet-derived growth factor receptor beta
相关
加载中…
  • Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma
    Sun, Jialing; Chen, Weicong; Wen, Bin; Zhang, Mingjia; Sun, Haitao; Yang, Xuemei; Zhao, Wenting; La, Lei; An, Haiyan; Pang, Jie; Gao, Lei*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 610158.被引 8
  • Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
    Yang, Xuemei; Sun, Jialing; Wen, Bin; Wang, Yu; Zhang, Mingjia; Chen, Weicong; Zhao, Wenting; He, Chunyu; Zhong, Xiaodan; Liu, Yang; Li, Tong; Sun, Haitao*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 771046.被引 4
  • Baicalin inhibits hepatocellular carcinoma cell growth and metastasis by suppressing ROCK1 signaling
    Sun, Jialing; Yang, Xuemei; Sun, Haitao; Huang, Shaohui; An, Haiyan; Xu, Wei; Chen, Weicong; Zhao, Wenting; He, Chunyu; Zhong, Xiaodan; Li, Tong; Liu, Yang; Wen, Bin*; Du, Qingfeng*; He, Songqi*Phytotherapy Research, 2023, 37(9): 4117-4132.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-01-30
卷期
第 301 卷
页码
115825
DOI
10.1016/j.jep.2022.115825
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science foundation of China; Basic and Applied Basic Research Fund of Guangdong; [81774037]; [82004077]; [2021A1515012591]; [2022A1515010007]

作者

  • C

    Chen, Weicong (第一作者)

    southern med univ

  • Y

    Yang, Xuemei

    southern med univ

查看全部 12 位作者收起作者
  • S

    Sun, Jialing

    guangzhou univ chinese med

  • C

    Chen, Yuyao

    southern med univ

  • Z

    Zhao, Wenting

    southern med univ

  • H

    He, Chunyu

    southern med univ

  • A

    An, Haiyan

    southern med univ

  • P

    Pang, Jie

    southern med univ

  • X

    Xu, Wei

    southern med univ

  • W

    Wen, Bin (通讯)

  • S

    Sun, Haitao (通讯)

    southern med univ

  • H

    He, Songqi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417